Chad Gwaltney, Ph.D.
– Senior Scientific Consultant
Dr. Gwaltney is currently Senior Scientific Consultant at PRO Consulting and Assistant Professor (Research) in the Department of Community Health at Brown University, Providence, RI, USA. He has published numerous articles and book chapters addressing patient-reported outcomes in fields such as addictive behaviors, cardiovascular health, and statistical methods for analyzing intensive self-report data. He has served on multiple international task forces addressing patient reported outcomes best practices, including his current role as leadership team member on the ISPOR Evidence of Content Validity Task Force. Additionally, Dr. Gwaltney serves on the editorial board of Psychology of Addictive Behaviors and is an investigator on 3 NIH-funded grants.
Where to Find Chad:
April 17-19, 2012: PROficiency 2012: PROs and Beyond, invivodata’s 5th Annual Conference; Naples, FL
January 25, 2012: DIA Sponsored Webinar – Using PROs to Assess Comparative Safety and Tolerability – Methodological and Regulatory Considerations
Comparing the safety and efficacy of new medical products to existing products can yield important information for all stakeholders in the healthcare industry. Patient-reported outcomes (PROs) may be used to assess the relative safety and tolerability of active treatments in comparative studies. This presentation, delivered through the Drug Information Association (DIA), will outline methodological and regulatory considerations when using PROs in this manner and describe applied examples.
Moderated by Dr. Gwaltney and presented by:
Laurie Burke, MPH,RPh Director for Study Endpoints and Labeling, Office of New Drugs, CDER, FDA
Ethan Basch, M.D., M.Sc., Associate Attending Physician, Department of Medicine Associate Outcomes Research Scientist, Department of Epidemiology and Biostatistics, Health Outcomes Memorial Sloan-Kettering Cancer Center
Jennifer Petrillo, PhD, PRO Expert, Novartis Pharmaceuticals
For more information and to register, click here: http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?pr
Follow the links below to access any of these recently recorded webinars in which Dr. Gwaltney presented PRO and/or ePRO-focused topics:
Webinar Replay: “How much do you know about the FDA Draft Guidance?”
Dr. Gwaltney leads an interactive Web Seminar that explores various elements of the FDA’s Draft Guidance on PROs in Clinical Research, including answers to the top 10 questions often asked by clinical researchers. View Webinar today!
Webinar Replay: Migration of PRO Measures from Paper to Electronic: Theoretical & Practical Perspectives
Dr. Gwaltney conducted a discussion of the validation activities required to migrate PRO measures from paper to electronic; a discussion on the recent meta-analysis on the impact of moving from paper to electronic, and practical strategies to successfully migrate from paper to electronic in the context of the FDA draft PRO Guidance. View webinar today!
